Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure

Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure

US Patent 10942175 · Granted Mar 9, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Circulating ESM-1 (endocan) in the assessment of atrial fibrillation and/or stro2025
IGFBP7 ratio for HFpEF2025
Biomarkers for risk assessment and treatment monitoring in heart failure patient2024
Biomarkers for risk assessment and treatment monitoring in heart failure patient2024
Circulating Angiopoietin-2 (Ang-2) and insulin-like growth factor-binding protei2024
IGFBP-7 as a marker of preeclampsia2024
IGFBP-7 as a marker of preeclampsia2024
GDF-15 and/or troponin T for predicting kidney failure in heart surgery patients2023
GDF-15 and/or troponin T for predicting kidney failure in heart surgery patients2023
GDF-15 and/or troponin T for predicting kidney failure in heart surgery patients2023
Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fi2023
Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fi2023